NCT04722523 2026-03-30
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
Memorial Sloan Kettering Cancer Center
OncoNano Medicine, Inc.
Regeneron Pharmaceuticals